96 related articles for article (PubMed ID: 29758495)
21. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
[TBL] [Abstract][Full Text] [Related]
22. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.
Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A
J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus glycoprotein B gene polymorphism and its association with clinical presentations in infants.
Mewara A; Mishra B; Ratho RK; Kumar P
Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):759-64. PubMed ID: 19842410
[TBL] [Abstract][Full Text] [Related]
24. A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells.
Brey CU; Proff J; Teufert N; Salzer B; Brozy J; Münz M; Pendzialek J; Ensser A; Holter W; Lehner M
Sci Rep; 2018 Nov; 8(1):17453. PubMed ID: 30487534
[TBL] [Abstract][Full Text] [Related]
25. Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection.
Görzer I; Kerschner H; Redlberger-Fritz M; Puchhammer-Stöckl E
J Clin Virol; 2010 Jun; 48(2):100-3. PubMed ID: 20362496
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles.
Curtsinger JM; Liu YN; Radeke R; Bryon MK; Fuad S; Bach FH; Gehrz RC
J Gen Virol; 1994 Feb; 75 ( Pt 2)():301-7. PubMed ID: 8113751
[TBL] [Abstract][Full Text] [Related]
27. Morphology and distribution of gp52 on extracellular human cytomegalovirus (HCMV) supports biochemical evidence that it represents the HCMV glycoprotein B.
Stannard LM; Rider JR; Farrar GH
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1553-60. PubMed ID: 2543788
[TBL] [Abstract][Full Text] [Related]
28. Human Cytomegalovirus (HCMV)-Specific Antibody Response and Development of Antibody-Dependent Cellular Cytotoxicity Against HCMV After Lung Transplantation.
Vietzen H; Görzer I; Honsig C; Jaksch P; Puchhammer-Stöckl E
J Infect Dis; 2020 Jul; 222(3):417-427. PubMed ID: 32157310
[TBL] [Abstract][Full Text] [Related]
29. Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations.
Arista S; De Grazia S; Giammanco GM; Di Carlo P; Iannitto E
Arch Virol; 2003 Mar; 148(3):547-54. PubMed ID: 12607105
[TBL] [Abstract][Full Text] [Related]
30. Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B.
Jun F; Minhuan L; Yadan M; Yaping H; Hanying L; Jianhua H; Hangping Y; Weihang M
Braz J Med Biol Res; 2012 Jul; 45(7):583-90. PubMed ID: 22618859
[TBL] [Abstract][Full Text] [Related]
31. Multiplex polymerase chain reaction for the evaluation of cytomegalovirus DNA load in organ transplant recipients.
Nazzari C; Gaeta A; Lazzarini M; Castelli TD; Mancini C
J Med Virol; 2000 Jun; 61(2):251-8. PubMed ID: 10797382
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype.
Aquino VH; Figueiredo LT
J Med Virol; 2000 May; 61(1):138-42. PubMed ID: 10745246
[TBL] [Abstract][Full Text] [Related]
33. Rapid and sensitive identification of glycoprotein H genotypes in clinical human cytomegalovirus samples.
Li W; Tao R; Zhang X; Shu Q; Gao HH; Shang SQ; Peng ZY; Li HM
Jpn J Infect Dis; 2015; 68(2):135-7. PubMed ID: 25420646
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of antigen and antibody detection in urine specimens from children with congenital human cytomegalovirus infection.
Koopmans M; Sánchez-Martinéz D; Patton J; Stewart J
J Med Virol; 1995 Aug; 46(4):321-8. PubMed ID: 7595408
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of three polymerase chain reaction tests targeting morphological transforming region II, UL-83 gene and glycoprotein O gene for the detection of human cytomegalovirus genome in clinical specimens of immunocompromised patients in Chennai, India.
Sowmya P; Madhavan HN; Therese KL
Virol J; 2006 Mar; 3():20. PubMed ID: 16571138
[TBL] [Abstract][Full Text] [Related]
36. A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.
Kauvar LM; Liu K; Park M; DeChene N; Stephenson R; Tenorio E; Ellsworth SL; Tabata T; Petitt M; Tsuge M; Fang-Hoover J; Adler SP; Cui X; McVoy MA; Pereira L
Antimicrob Agents Chemother; 2015 Mar; 59(3):1558-68. PubMed ID: 25534746
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
Ludwig B; Kraus FB; Kipp M; Preiser W; Schwerdtfeger R; Doerr HW; Buxbaum S
J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard.
Genser B; Truschnig-Wilders M; Stünzner D; Landini MP; Halwachs-Baumann G
Clin Chem Lab Med; 2001 Jan; 39(1):62-70. PubMed ID: 11256803
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody.
Spindler N; Diestel U; Stump JD; Wiegers AK; Winkler TH; Sticht H; Mach M; Muller YA
PLoS Pathog; 2014 Oct; 10(10):e1004377. PubMed ID: 25299639
[TBL] [Abstract][Full Text] [Related]
40. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
